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ABSTRACT 
Objective. Large-scale disasters may disrupt health surveillance systems, 
depriving health officials and researchers of timely and accurate information 
needed to assess disaster-related health effects and leading to use of less 
reliable self-reports of health outcomes. In particular, ascertainment of cancer 
in a population is ordinarily obtained through linkage of self-reported data with 
regional cancer registries, but exclusive reliance on these sources following 
a disaster may result in lengthy delays or loss of critical data. To assess the 
impact of such reliance, we validated self-reported cancer in a cohort of 59,340 
responders and survivors of the World Trade Center disaster against data from 
11 state cancer registries (SCRs). 
Methods. We focused on residents of the 11 states with SCRs and on cancers 
diagnosed from September 11, 2001, to the date of their last survey participa-
tion. Medical records were also sought in a subset of 595 self-reported cancer 
patients who were not recorded in an SCR. 
Results. Overall sensitivity and specificity of self-reported cancer were 83.9% 
(95% confidence interval [CI] 81.9, 85.9) and 98.5% (95% CI 98.4, 98.6), respec-
tively. Site-specific sensitivities were highest for pancreatic (90.9%) and testicu-
lar (82.4%) cancers and multiple myeloma (84.6%). Compared with enrollees 
with true-positive reports, enrollees with false-negative reports were more likely 
to be non-Hispanic black (adjusted odds ratio [aOR] 5 1.8, 95% CI 1.2, 2.9) or 
Asian (aOR52.2, 95% CI 1.2, 4.1). Among the 595 cases not recorded in an 
SCR, 13 of 62 (21%) cases confirmed through medical records were reportable 
to SCRs. 
Conclusion. Self-report of cancer had relatively high sensitivity among adults 
exposed to the World Trade Center disaster, suggesting that self-reports of 
other disaster-related conditions less amenable to external validation may also 
be reasonably valid.
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Identification and tracking of long-term physical and 
mental health effects of man-made and natural disas-
ters often rely on self-reports of clinically diagnosed 
health conditions obtained longitudinally through 
questionnaires,1 but the accuracy of such self-reported 
diagnoses is often difficult to assess because of large 
sample sizes and limited funding. Accuracy of self-
reported health data can depend on such factors as 
type of condition, study population demographics, and 
recall period length.2–9
Linkage of cohort data with independent cancer 
registries enables assessment of cancer self-report 
accuracy and may reflect self-report accuracy of other 
endpoints for which no outside data are available. The 
sensitivity of self-reported cancer is reported to vary by 
site, treatment, and number of previous tumors.6,10–12 
False-negative self-report of cancer diagnoses deter-
mined by comparison with cancer registry data is 
associated with older age,6,11,13 nonwhite race, increased 
time since cancer diagnosis,6 lower education level,2,8 
male sex, and urban living.2 
The World Trade Center (WTC) Health Registry 
(WTCHR) has followed a cohort of 71,434 people since 
2003 to identify and track the long-term health effects 
of the September 11, 2011 (hereinafter 9/11), terrorist 
attacks through surveys.14 Although the WTCHR peri-
odically requests to compare its data with those of other 
health registries, such as state cancer registries (SCRs) 
and the Statewide Planning and Research Coopera-
tive System, the time lags between diagnosis and data 
availability for comparison often limits timely surveil-
lance of emerging or rare health conditions. Thus, the 
accuracy of self-reported health information, including 
cancer diagnosis, provided by WTCHR enrollees at 
enrollment and in subsequent waves is important. We 
examined the performance of self-reported health data 
collected by the WTCHR, using cancer as an example, 
by comparing WTCHR survey data with data obtained 
via linkage with SCRs to validate self-reported cancer 
diagnosis. We also examined correlates of false-negative 
and false-positive reports. 
METHODS
The World Trade Center Health Registry
The WTCHR is a cohort study of 71,434 people who 
were directly exposed to the destruction of the WTC 
and surrounding buildings and its aftermath. Details of 
eligibility and recruitment are available elsewhere.14,15 
In brief, people with potential exposure were recruited 
from lists of businesses and building occupants and via 
public outreach and media campaigns. Potential enroll-
ees were screened for eligibility, with those enrolled 
belonging to one or more of the following groups: 
rescue/recovery workers and volunteers, lower Manhat-
tan residents, area workers, passersby, schoolchildren, 
and school staff members. Baseline data (Wave 1) 
were gathered in 2003–2004 via computer-assisted tele-
phone interview (95%) or in-person interview (5%). 
Wave 1 data included data on demographics, current 
health status, medical history, and exposure. An adult 
follow-up survey (Wave 2) conducted from November 
2006 through December 2007 (response rate: 68%, 
n546,602/68,959) obtained additional exposure data 
and updated health information.16 The final cohort 
(n571,434) consisted of 30,664 (42.9%) responders 
(rescue/recovery workers and volunteers) and 40,770 
(57.1%) survivors (residents, passersby, area workers, 
schoolchildren, and school staff members in Lower 
Manhattan on the morning of 9/11). 
Study sample 
The study sample for this analysis was limited to adult 
enrollees aged $18 years at enrollment (Wave 1) who 
completed cancer questions in Wave 1 or follow-up 
(Wave 2) surveys. The study was also limited to residents 
since 9/11 of the 11 states (California, Connecticut, 
Florida, Massachusetts, New Jersey, New York, North 
Carolina, Ohio, Pennsylvania, Texas, and Washington) 
in which we conducted cancer record linkage. We 
excluded proxies and withdrawals and included only 
cancers—reported either by enrollees or the SCRs—
that were diagnosed between September 12, 2001, 
and the date of their last survey participation (Wave 1 
or Wave 2). A total of 59,340 enrollees met inclusion 
criteria (Figure 1). 
Self-reported cancer
In Wave 1, we asked (1) “Have you ever been told by 
a doctor or other health professional that you had 
cancer or a malignancy of any kind?”, (2) “Did a doc-
tor or other health professional first tell you that you 
had cancer or a malignancy of any kind before 9/11 
or after 9/11?”, and (3) “What kind of cancer was it?” 
with a drop-down menu of cancer sites. Wave 2 had 
similar questions, but the question about cancer site 
required an open-ended response and inquired about 
year of diagnosis. A self-reported post-9/11 cancer was 
defined as a positive answer to the first cancer question 
and a reported diagnosis after 9/11. 
Cancer identified from cancer registry linkages
We matched enrollees with the people registered in the 
11 SCRs, all of which adopted Link Plus, a probabilistic 
record linkage program developed by the Centers for 
Disease Control and Prevention.17 We provided full 
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name, sex, race/ethnicity, birth date, complete address 
of residence, and social security number when avail-
able to each SCR. Matches were reported by each SCR; 
also reported by each SCR was information on primary 
cancer site(s), histology, stage, diagnosis date, and state 
where cancer was diagnosed. Linked cancer data from 
all SCRs were available through December 31, 2008. 
Cancer site was defined according to the International 
Classification of Diseases for Oncology, Third Edition, 
and grouped by using the Surveillance Epidemiology 
and End Results (SEER) site recode codes for primary 
site and histology.18 
Medical record confirmation of false-positive report
We investigated self-reports of cancer that were not 
also confirmed by the SCRs by contacting enrollees’ 
physicians for confirmation of cancer diagnoses. This 
investigation required first contacting the enrollees for 
permission to communicate with their physicians and 
then reviewing relevant medical reports and records. 
Because of limited resources, we carried out this inves-
tigation from June 2009 to January 2010 only among 
the 595 enrollees then living in New York State.
Data analysis
We evaluated the performance of self-report using 
sensitivity, specificity, and positive predictive value 
(PPV). We defined a true-positive report of cancer 
as a self-report of cancer recorded in an SCR, a false-
negative report of cancer as non-self-report of cancer 
that was recorded in an SCR, a false-positive report of 
cancer as a self-report not recorded in an SCR, and a 
true-negative report of cancer as a non-report and non-
recorded cancer (Figure 2). We defined sensitivity as 
the proportion of true-positive reports among recorded 
cancers. We defined specificity as the proportion of 
true-negative reports among non-recorded cancers. We 
defined positive predictive value (PPV) (i.e., agreement 
aRefers to people who resided in any of the 11 states for which matched state cancer registry data were obtained: California, Connecticut, 
Florida, Massachusetts, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Texas, and Washington.
SCR 5 state cancer registry
Figure 1. Flow diagram of people enrolled in the World Trade Center Health Registry cohort who self-reported 
cancer compared with records in a state cancer registry, 2003–2004a
71,434 individuals enrolled in World Trade Center  
Health Registry cohort in 2003–2004
12,094 excluded
 4,535 Did not reside in any of 11 states during the study 
period
 3,848 Responded to either wave by proxy or were ,18 years 
of age
 1,248 Recorded cancer diagnosed after the last date of survey 
participation
 1,250 Recorded cancer diagnosed prior to 9/11/2001
 1,040 Self-reported cancer diagnosed prior to 9/11/2001
 170 Did not answer survey question on cancer
 3 Withdrew
59,340 eligible for data analysis
57,431 (96.8%)  
did not report  
any post-9/11 cancer
1,909 (3.2%)  
reported  
post-9/11 cancer
201 (0.3%) recorded  
in state cancer  
registry (SCR)
57,230 (99.7%)  
had no cancer  
recorded in SCR
1,047 (54.8%)  
recorded in SCR
862 (45.2%)  
had no cancer  
recorded in SCR
Self-Report of Post-9/11 Cancer Diagnosis  423
Public Health Reports / May–June 2016 / Volume 131
of self-report with SCR) as the proportion of true-
positive reports among all self-reports (true-positive 
reports and false-positive reports). 
A matched cancer site refers to verification of the 
anatomical site of the self-reported cancer using SEER 
site recode rules. The term false-positive is used for 
consistency with standard validation analyses and does 
not imply that those reporting cancer actually do not 
have cancer. We recognize that a cancer may not have 
been reported to the SCR for various reasons. Under-
standing that a matched individual may not match to 
the cancer site, we assessed the performance of self-
report separately, by individual and by site. 
We performed bivariate and multivariable analyses 
using logistic regression modeling to assess whether 
enrollees’ sociodemographic characteristics, medical 
history, or number of cancer sites were associated 
with either false-negative or false-positive reports. We 
computed unadjusted odds ratios (ORs), adjusted odds 
ratios (aORs), and 95% confidence intervals (CIs). The 
OR represents the odds of having a false-negative or 
false-positive report given the presence of a variable 
of interest, compared with the odds of having a false-
negative or false-positive report given the absence of 
a particular variable of interest. We computed aORs 
and 95% CIs using a multivariate model in which 
variables such as sociodemographics, Wave 2 participa-
tion, history of other medical conditions, and probable 
posttraumatic stress disorder (PTSD) were included if 
they were significantly associated with false-negative or 
false-positive reporting in bivariate analyses. We evalu-
ated socioeconomic status as a combination of annual 
household income and education at three levels: low 
(education #12 years and annual household income 
,$25,000), high ($college degree and annual house-
hold income $$50,000), and intermediate (between 
low and high socioeconomic status). In analyzing 
people with false-positive reports, we excluded enroll-
ees who reported only non-melanoma or unspecified 
skin cancers because these tumors are not reportable 
to SCRs. 
We also examined whether or not a positive response 
to the Wave 1 cancer question was consistent with the 
Wave 2 response by computing percentages and 95% 
CIs of agreement. We performed all data analyses using 
SAS® version 9.2.19 
RESULTS
Sensitivity and specificity of self-report
Overall sensitivity and specificity of self-report were 
83.9% (95% CI 81.9, 85.9) and 98.5% (95% CI 98.4, 
98.6), respectively. Sensitivity was greater among partici-
pants in Wave 1 and Wave 2 than among participants 
in Wave 1 only (87.5% vs. 67.3%); however, specific-
ity was not substantially different between these two 
groups (Table 1). 
Of 1,909 enrollees who reported a cancer diagnosis, 
1,393 (73.0%) specified a single cancer site, 80 (4.2%) 
reported two or more sites, and 436 (22.8%) did not 
specify any site. Sensitivity varied by site. The highest 
site-specific sensitivities for self-report of cancer were 
observed for pancreatic (90.9%), multiple myeloma 
(84.6%), and testicular (82.4%) cancers. The highest 
PPV of self-reported cancer was for multiple myeloma 
(100.0%), followed by prostate (93.5%) and testicular 
(93.3%) cancers, while the lowest was for melanoma 
of the skin (40.5%) (Table 1). 
Factors associated with false-negative report
Of the 1,248 enrollees with a primary cancer site 
recorded in an SCR, 201 (16.1%) did not report hav-
ing any cancer diagnosed in either wave (Table 1). 
Compared with the 1,047 enrollees with true-positive 
reports, enrollees with false-negative reports were more 
likely to be Wave 2 nonparticipants (aOR52.9, 95% CI 
2.0, 4.1), non-Hispanic black (aOR51.8, 95% CI 1.2, 
2.9) or Asian (aOR52.2, 95% CI 1.2, 4.1), or have not 
Figure 2. Definitions of measures used to assess the performance of self-report of cancer among people enrolled 
in the World Trade Center Health Registrya compared with records in a state cancer registry, 2001–2007b
Record status in a state cancer registry
Recorded Not recorded
Self-report status of  
 cancer diagnosis
Self-reported True-positive report (TPR) False-positive report (FPR)
Not self-reported False-negative report (FNR) True-negative report (TNR)
aRefers to people who resided in any of the 11 states for which matched state cancer registry data were obtained: California, Connecticut, 
Florida, Massachusetts, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Texas, and Washington.
bSensitivity of self-report 5 TPR/(TPR1FNR); specificity of self-report 5 TNR/(FPR1TNR); positive predictive value of self-report 5 TPR/
(TPR1FPR)
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provided a social security number (aOR51.6, 95% CI 
1.0, 2.6) (Table 2). Enrollee characteristics such as age, 
sex, smoking status, history of cardiovascular disease, 
emphysema, diabetes, or PTSD were not associated 
with false-negative reports. A non-English-language 
Wave 1 interview was strongly associated with false-
negative report in bivariate analyses (OR53.7, 95% 
CI 2.0, 6.9). However, this variable was excluded from 
multivariable analyses because of strong collinearity 
with socioeconomic status. 
Factors associated with false-positive report
A total of 1,909 enrollees reported having post-9/11 
cancer diagnosed during the study period, of whom 862 
(45.2%) were not recorded in an SCR. Of these 862 
enrollees, 31 (3.6%) reported more than one cancer 
and 390 (45.2%) reported non-melanoma or unspeci-
fied skin cancer that was not reportable to an SCR. 
After excluding the 390 non-reportable non-mela-
nomas or unspecified skin cancer cases, we compared 
472 enrollees who had false-positive reports with 1,047 
enrollees who had true-positive reports (Table 3). Sev-
eral factors that were not associated with false-negative 
reports were associated with false-positive reports as 
compared with true-positive reports. Enrollees with 
false-positive reports were more likely than enrollees 
with true-positive reports to be younger (aOR53.6, 
95% CI 1.0, 13.6 for adults aged 18–24 years; aOR52.3, 
95% CI 1.8, 3.0 for adults aged 25–44 years), current 
smokers than never smokers (aOR51.9, 95% CI 1.3, 
2.6), and to have probable PTSD than not (aOR51.7, 
95% CI 1.3, 2.3) in the adjusted model. Factors such as 
race/ethnicity and providing a social security number 
that were associated with false-negative reports were 
not associated with false-positive reports. Those who 
did not participate in Wave 2 were less likely than those 
who did to have false-positive reports (aOR50.6, 95% 
CI 0.4, 0.8).
Medical record confirmation 
In the sub-analysis of 595 New York State residents for 
whom we sought medical record confirmation of self-
reported cancer, 260 enrollees (43.7%) responded to 
our investigation; 138 (53.1%) claimed they had never 
had a cancer diagnosis, 92 (35.4%) gave permission for 
us to obtain further information from their physician, 
and 30 (11.5%) refused to give permission. Among 
those who gave permission, 62 self-reported cancer 
cases (67.4%) were physician confirmed, 19 (20.7%) 
were physician confirmed as not having cancer, eight 
(8.7%) were not confirmed because the treating 
physicians failed to provide information, and three 
(3.3%) were not confirmed because medical records 
could not be located. Among the 62 self-reported can-
cers confirmed by primary or treating physicians, 13 
were reportable cancer cases and the remaining were 
non-reportable cancers because they were either non-
melanoma skin cancer or benign tumors. 
Consistency of self-report of cancer in both waves 
When asked at Wave 1, “Have you ever been told by a 
doctor or other health professional that you had cancer 
or a malignancy of any kind?”, 611 of 39,531 people 
who participated in both Wave 1 and Wave 2 answered 
affirmatively. When asked the same question in Wave 
2, 560 (91.7%) of these 611 enrollees again answered 
affirmatively, and 51 (8.3%) provided inconsistent 
answers. The cancer linkage proportion was 60.9% 
(n5341/560) for enrollees who provided consistent 
answers and 17.6% (n59/51) for those who provided 
inconsistent answers.
DISCUSSION
This study examined the performance of self-reported 
cancer diagnoses in a 9/11-exposed cohort and iden-
tified correlates of false-negative and false-positive 
reporting. Sensitivity of self-reported cancer among 
those who responded to both surveys was relatively high 
(87.5%). It was also higher than in several other U.S. 
studies using cancer registry data as the gold standard 
(60.8%–74.2%)3,6,20 and similar studies conducted in 
other countries (40.0%–57.5%).8,13,21 The relatively high 
sensitivity in this study may be attributable to the use 
of multiple SCRs, to giving participants an opportunity 
to report a diagnosis twice (during Wave 1 and Wave 
2), or to the relatively short recall period (2–6 years) 
compared with other studies (.20 years).6,11 
The site-specific sensitivity varied considerably and 
was low for cancers in the oral cavity and the pharynx 
(22.2%) or brain and other nervous system (31.8%), 
indicating substantial underreporting of these cancer 
sites in the study sample. False-negative reporting 
among non-Hispanic black and Asian patients and 
those who did not provide a social security number 
was also prevalent. Similar findings were reported in a 
community-based study where the most often underre-
ported cancer sites were central nervous system and lip, 
oral cavity, and pharynx, and nonwhite patients were 
10 times more likely than white patients to provide a 
false-negative report of their cancer history.6 
Knowing the patterns of false-negative reporting 
is important for surveillance of cancer incidence 
among WTCHR enrollees because high validity of self-
reported cancer data collected from follow-up surveys 
may partially compensate for the delay in time from 
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diagnosis to data availability in the cancer registry and 
provide insight into the validity of cancers that are 
not reportable to the SCR. Studies examining false-
negative reporting have cited factors such as being 
less informed about the diagnosis (possibly related to 
cultural differences in communication) or mistrust 
of health-care professionals or study interviewers.6,13 
Researchers might improve reporting of health condi-
tions by adopting other researchers’ methods. Methods 
for enhancing response accuracy include providing a 
clear definition of the respondent’s task, improving 
respondent’s motivation, and facilitating cognitive 
processing.22 These methods are particularly important 
because African Americans had the highest overall 
cancer incidence and mortality rates between 2000 
and 2004 among all races in the United States23 and 
high incidence and mortality rates overall for other 
health conditions.24–26 
Not completing a follow-up survey (Wave 2) was 
associated with false-negative reporting, which may 
have resulted from not having a second opportunity 
to report a cancer diagnosis or because of confound-
ing factors associated with both nonparticipation and 
a cancer diagnosis. Those who did not complete the 
Wave 2 survey were more likely than those who com-
pleted Waves 1 and 2 to be older ($65 years of age), 
have a lower annual household income (,$25,000), 
or be current smokers, all of which are reported to be 
associated with false-negative reporting.2,6,8,11 
Limitations
This study had several limitations. First, one possible 
explanation for false-positive reporting is that self-
reported cancer could not be verified in this study if the 
cancer was reported outside coverage of the 11 SCRs. 
Second, some cancers that were reported on the survey 
may not be reportable to SCRs. In our investigation of 
a subset of reports of cancer that were not confirmed 
by the SCRs, a large proportion of cancers confirmed 
by treating physicians were not reportable to an SCR. 
Thus, we would expect this discrepancy to result in 
some false-positive reports. Completeness and accuracy 
of data from the 11 SCRs used in this study have been 
reported to be relatively high,27,28 so this explanation 
for false-positive reports is unlikely. Third, self-report 
is subject to recall bias. Cancer was not covered by the 
September 11 Victim Compensation Fund until 2012,29 
five years after data used in this study were collected. 
As such, false-positive reports were unlikely to have 
been influenced by a desire to obtain financial support 
from the fund’s existence. 
CONCLUSION
Published WTC-related studies have largely relied on 
self-reported data. The findings in this study support 
the use of survey data for ongoing timely surveillance of 
adverse health conditions such as cancer. Self-reported 
cancer can be used to complement cancer linkage with 
cancer registries. 
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